A novel adaptive spectrum forming filter: Application in cognitive ultra-wideband

Bin Li,Zheng Zhou,Wei-xia Zou

DOI: https://doi.org/10.1007/s11432-010-4106-6

2010-11-26

Science China Information Sciences

Abstract:

What problem does this paper attempt to address?

Advances of diagnosis in children with cyclic vomiting syndrome

Alessandra Zicari,Giovanni Corrado,Claudia Pacchiarotti,Sandra Lucarelli,Tullio Frediani,Marisa Cavaliere,Mariassunta Porcelli,Ettore Cardi

DOI: https://doi.org/10.3969/j.issn.1000-3606.2008.10.002

2008-01-01

Abstract:Cyclic vomiting syndrome (CVS) usually begins in childhood,mainly in preschool age children.It is a recurrent and stereotypic episodic disorder of high intensity nausea and vomiting lasting for hours or days,separa- ted by intervals free of symptoms for weeks or months.Attacks have an "on-off" pattern.In the last decade,it becomes consensus that CVS is a functional gastrointestinal disorder,and the diagnostic criteria have been published one after the other.The diagnostic criteria proposed in 1994 suggested four essential clinical features of CVS and related suppor- tive criteria.Rome Ⅱ and Rome Ⅲ criteria of CVS have been published in 1999 and 2006,respectively.The diagnosis of CVS is primarily based on history and typical clinical presentation,physieal examination,and basic laboratory stu- dies.It is necessary that other known and treatable disorders should be excluded before the diagnosis of CVS,especially severe or even life-threatening disorders including many of the anatomic disorders.CVS should be also differentiated from migraine headaches and abdominal migraines according to their characteristic features. (J Clin Pediatr,2008,26 (10):830-834)
Cyclic vomiting syndrome: A narrative review and guide to management

Katja Kovacic,B U K Li

DOI: https://doi.org/10.1111/head.14073

Abstract:Objectives/background: Cyclic vomiting syndrome (CVS) is a disabling disorder of gut-brain interaction manifested by stereotypical and severe episodes of nausea and vomiting. Prevalence data indicate that CVS affects 1-2% of children and there has been a recent dramatic rise in diagnosed adults. Methods: This narrative review summarizes relevant literature pertaining to pediatric and adult CVS and provides a guide to management based on extensive clinical experience. Results: More timely diagnosis is facilitated by an expert consensus diagnostic approach and limited testing. Some diagnostic tests of exclusion remain essential. These include an upper gastrointestinal (GI) contrast study to exclude intestinal malrotation and basic laboratory screening. An abdominal ultrasound is recommended to exclude renal hydronephrosis in children and biliary disease in adults. Exclusion of metabolic/genetic conditions is warranted in those with specific warning signs, presentation in infants/toddler age, and in those with refractory disease. In the absence of chronic GI symptoms, referral to a GI specialist for upper endoscopy is generally not necessary in children but recommended in adults. A large subset termed migraine-equivalent CVS display strong clinical and genetic features of migraine. A unifying pathophysiologic core concept involves neuronal hyperexcitability and aberrant central modulation of autonomic signals. This is coupled with multiple susceptibility factors including mitochondrial dysfunction/cellular energy deficits, a hyper-responsive hypothalamic-pituitary-adrenal axis and many comorbidities that increase vulnerability to triggering events. CVS episodes are frequently triggered by stressors and intercurrent illnesses. Lifestyle and non-pharmacological interventions thus play a pivotal role in successful management. Pharmacological therapies are categorized into abortive, supportive/rescue, and prophylactic treatments. The majority respond particularly well to migraine-focused treatment strategies. Conclusion: Despite improved characterization and understanding, CVS remains classified as a functional disorder of brain-gut interaction that is often disjointly managed by generalists and subspecialists. Early recognition, evaluation, and management will facilitate care and improve outcomes. Further research into its natural history with common progression to migraine headaches, neuroendocrine mechanisms, and the pathophysiologic relation to migraine diathesis is much needed.
Lumbar extensor fatigue and circumferential ankle pressure impair ankle joint motion sense

Kevin M Pline,M. Madigan,M. Nussbaum,R. Grange

DOI: https://doi.org/10.1016/j.neulet.2005.07.047

IF: 3.197

2005-12-16

Neuroscience Letters

Abstract:
Cyclic Vomiting Syndrome in Children and Adults: What Is New in 2018?

Katja Kovacic,Manu Sood,Thangam Venkatesan

DOI: https://doi.org/10.1007/s11894-018-0654-5

2018-08-29

Current Gastroenterology Reports

Abstract:Purpose of ReviewCyclic vomiting syndrome (CVS) is a disabling functional gastrointestinal disorder characterized by severe vomiting episodes that alternate with symptom-free periods. The purpose of this review is to summarize current knowledge and highlight most recent data on prevalence, diagnosis, management, and impact of CVS in children and adults.Recent FindingsOriginally thought to be a pediatric disorder, the past decade has witnessed a considerable increase in CVS diagnosed in adults. Despite improved recognition of CVS, without a delineated pathophysiology and specific biomarker, it remains classified as a functional gastrointestinal disorder. Migraines and CVS share a common pathway based on several studies and response to migraine therapy. Recent work has begun to expand the list of comorbidities and identify plausible mechanisms and new therapeutic avenues.SummaryThis review seeks to highlight best practices and novel therapies for CVS based on expert consensus and review of available literature.
Reversible Splenial Lesion Syndrome in Children with Benign Convulsions Associated with Mild Gastroenteritis: A Retrospective Study of Five Cases

Lihua Jiang,Shanshan Mao,Jialu Xu,Feng Gao

DOI: https://doi.org/10.1016/j.braindev.2018.10.004

2019-01-01

Abstract:Objective: To assess the clinical and imaging features of reversible splenial lesion syndrome (RESLES) with benign convulsions associated with mild gastroenteritis (CwG) in children. Patients and methods: We retrospectively reviewed the clinical course, blood and stool examinations, cerebrospinal fluid (CSF) examination, magnetic resonance imaging (MR1), electroencephalography (EEG) findings, therapy and prognosis of five children with RESLES associated with CwG. Results: Five previously healthy patients, four girls and one boy, with mean age 26.4 +/- 8.1 months, had clusters of general tonicclonic or clonic seizures within the first two days of gastroenteritis. Rotavirus antigen was positive in the stool of one case. Interictal EEG was normal except in one case, which showed occipital slow wave. The initial MRI was performed within five days of onset, four patients had an isolated lesion in the splenium of the corpus callosum (SCC), and one patient had lesions extending outside the SCC that involved the genu of the corpus callosum. The follow-up MRI was performed 10-15 days after onset, and all lesions had completely disappeared. All patients were treated with antiviral, rehydration and anticonvulsant therapy in the acute phase. They had good prognosis and normal psychomotor development, with no neurological sequelae after 26-30 months of follow-up. Conclusions: CwG and RESLES can coexist in young children. The patients present with clusters of general tonic-clonic or clonic seizures in the acute phase. Brain MRI shows focal lesion in the SCC with high signal intensity on T2-weighted and FLAIR sequences. It has good prognosis and excessive treatment is not necessary. (C) 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Children with Cyclic Vomiting Syndrome: Phenotypes, Disease Burden and Mitochondrial DNA Analysis

Ziqing Ye,Aijuan Xue,Ying Huang,Qiye Wu

DOI: https://doi.org/10.1186/s12876-018-0836-5

2018-01-01

BMC Gastroenterology

Abstract:Cyclic vomiting syndrome (CVS) is characterized by repeated, stereotypical vomiting episodes. It is possibly associated with mitochondrial DNA (mtDNA) variants. We examined the phenotype, disease burden, treatment and performed mtDNA analysis in pediatric CVS.
Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders

Elliot S. Yu,Yasodara Priyadharsini S.S.,Thangam Venkatesan

DOI: https://doi.org/10.1007/s11938-018-0202-2

2018-10-25

Current Treatment Options in Gastroenterology

Abstract:Purpose of reviewCyclic vomiting syndrome (CVS) is a chronic functional gastrointestinal disorder characterized by episodic nausea and vomiting and is diagnosed using Rome IV criteria. CVS is being recognized more frequently in adults with a prevalence of 2%. It is associated with several functional disorders like autonomic dysfunction, anxiety, and depression, but the strongest association is with migraine. We will elucidate the close relationship between migraine and CVS and briefly discuss its association with other gastrointestinal disorders.Recent findingsWe highlight similarities in pathophysiology, clinical presentation, and response to medications between CVS and migraine (tricyclic antidepressants, triptans, antiepileptics). We also discuss novel therapies like CGRP inhibitors which are effective in migraine and have potential for adaptation in patients with CVS.SummaryUsing migraine as a template should enable investigators to elucidate the mechanisms underlying this disorder, develop novel therapies, and direct future research in CVS.
Mitochondrial HMG-CoA Synthase Deficiency: A Cyclic Vomiting Mimic Without Reliable Biochemical Markers

Annie D Niehaus,Holly Cooper,Chung U Lee

DOI: https://doi.org/10.1177/23247096241267154

Abstract:Here, we report an individual, eventually diagnosed with HMG-CoA synthase deficiency, who presented with a cyclic vomiting phenotype. HMG-CoA synthase deficiency is a rare disorder affecting ketone body synthesis in which affected individuals typically present at a young age with hypoketotic hypoglycemia, lethargy, encephalopathy, and hepatomegaly, usually triggered by catabolism (e.g., infection or prolonged fasting). This individual presented with recurrent episodes of vomiting and lethargy, often associated with hypoglycemia or hyperglycemia, at 3 years of age. Metabolic labs revealed nonspecific abnormalities in her urine organic acids (showing mild elevation of dicarboxylic acids with relatively low excretion of ketones) and a normal acylcarnitine profile. Given her clinical presentation, as well as a normal upper gastrointestinal series, esophagogastroduodenoscopy with biopsies, and abdominal ultrasound, she was diagnosed with cyclic vomiting syndrome at 3 years of age. Molecular testing completed at 7 years of age revealed a previously reported pathogenic sequence variant (c.1016+1G>A) and a novel likely pathogenic deletion (1.57 kB deletion, including exon 1) within HMGCS2 consistent with HMG-CoA synthase deficiency. This individual's presentation, mimicking cyclic vomiting syndrome, widens the clinical spectrum of HMG-CoA synthase deficiency. In addition, this case highlights the importance of molecular genetic testing in such presentations, as this rare disorder lacks specific metabolic markers.
Exploring cyclic vomiting syndrome (CVS) worldwide: Current epidemiological insights and recent developments

Rosita Frazier,Uday C. Ghoshal,Jose Remes‐Troche,Dover Robin,Emoto Shun,Thavamani Aravind

DOI: https://doi.org/10.1111/nmo.14932

2024-10-08

Neurogastroenterology & Motility

Abstract:Background Cyclic vomiting syndrome (CVS), a disorder of gut–brain interaction, presents with recurrent episodes of severe nausea and vomiting. It is often associated with missed or delayed diagnoses and substantial healthcare utilization. Despite historical recognition dating back to the 19th century, epidemiological insights remain limited, with research predominantly originating from specific regions, such as the US. CVS prevalence and incidence rates vary widely and are hindered by inconsistent methodologies and disease recognition. Purpose This review aims to provide a comprehensive overview of CVS prevalence and incidence rates. It reviews the currently available data and identifies gaps in knowledge. Understanding the global epidemiology of CVS, increasing awareness of the disease, and fostering global collaboration are crucial. Other pertinent issues include disparities in outcomes, particularly among African Americans and Hispanics in the United States, underscoring the need to understand the social determinants of health that drive disease outcomes. This understanding can inform targeted interventions to address these barriers and achieve equitable healthcare both in the United States and globally.

gastroenterology & hepatology,neurosciences,clinical neurology
Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium

William L. Hasler,B. U. K. Li,David J. Levinthal,Thangam Venkatesan

DOI: https://doi.org/10.1111/nmo.14825

2024-05-24

Neurogastroenterology & Motility

Abstract:Background An increasing number of studies have explored the clinical features, epidemiology, pathophysiology, and management of cyclic vomiting syndrome (CVS). CVS is common in adults and children and negatively impacts patients, families, and the healthcare system. A related condition, cannabinoid hyperemesis syndrome (CHS), has been a focus of interest in the lay press and published literature. Purpose Clinical presentations of CVS have been defined by small series and expert opinion, but recent prospective studies are refining our understanding of the spectrum of emetic episodes and the breadth of comorbid conditions. Large cross‐sectional population analyses are clarifying CVS prevalence and factors related to age, ethnicity, and geographic region. CVS pathophysiology is multifactorial with contributions from migraines, dysautonomia, endogenous cannabinoids, mitochondrial dysfunction, genetic abnormalities, and rapid gastric emptying. CVS treatment relies on antiemetics and antimigraine therapies to abort acute episodes coupled with prophylactic regimens employing neuromodulators and antiepileptics. CHS represents a challenge partly because of difficulties in achieving sustained cannabis abstinence. Benefits of other therapies in CHS remain poorly defined. Several areas warrant further scrutiny including better identification of CVS triggers and characterization of different CVS subsets including those with frequent severe episodes, refined description of epidemiology to allow targeting of populations predisposed to CVS development, rigorous definition of pathogenic factors to provide a foundation for exploratory studies of novel therapies, and conduct of controlled trials by multicenter collaborations to confirm benefits of existing and new therapies in development. Progress in these areas will be facilitated by generous governmental and industry support.

gastroenterology & hepatology,neurosciences,clinical neurology
S803 Recent Findings on Clinical and Economic Outcomes of Cyclic Vomiting Syndrome: An Analysis of the National Inpatient Database

Faris Shweikeh,Abdur Rahman Jabir,Madison Simons,Samita Garg,Michael Cline,Scott Gabbard,Matthew Hoscheit,Anthony J. Lembo

DOI: https://doi.org/10.14309/01.ajg.0001032580.14529.f1

2024-10-26

The American Journal of Gastroenterology

Abstract:Cyclic Vomiting Syndrome (CVS) is a poorly understood disorder of gut-brain interaction (DGBI) characterized by recurring episodes of intractable nausea and vomiting. The aim of this study was to assess clinical, economic, and epidemiological characteristics of hospitalized patients in the United States with CVS.

gastroenterology & hepatology
Recurrent Severe Vomiting Due to Hyperthyroidism

Li-ying Chen,Bo Zhou,Zhou-wen Chen,Li-zheng Fang

DOI: https://doi.org/10.1631/jzus.b0900371

2010-01-01

Journal of Zhejiang University SCIENCE B

Abstract:Thyrotoxicosis may present in many ways; severe vomiting as a prominent symptom of thyrotoxicosis is uncommon. In this paper, we report a 24-year-old Chinese male with hyperthyroidism who presented with recurrent severe vomiting. The patient had had intermittent vomiting for seven years and had lost approximately 15 kg of weight. Gastroscopic examinations revealed chronic gastritis and one occasion peptic ulcer. He was treated with antacid and proton pump inhibitors, but his symptoms had no relief. His presenting symptoms suggested hyperthyroidism and were confirmed by laboratory data. After a month of propylthiouracil therapy, his symptoms were relieved. It should be noted that hyperthyroidism patients can have unexplained vomiting, and that hyperthyroidism may coexist with peptic ulcer in rare cases. Awareness of such atypical presentations of hyperthyroidism may help to make a correct diagnosis.
Cardiac Vagal Regulation is Impeded in Children with Cyclic Vomiting Syndrome

Jacek Kolacz,Katja Kovacic,Linh Dang,B U.K. Li,Gregory F. Lewis,Stephen W. Porges

DOI: https://doi.org/10.14309/ajg.0000000000002207

2023-02-01

Abstract:The pathophysiology underlying cyclic vomiting syndrome (CVS) remains undefined. Scant data and distinct clinical features point to altered autonomic nervous system function. Autonomic signaling can be non-invasively assessed via cardiac indices of parasympathetic vagal regulation, which is reduced in children with disorders of gut-brain interaction. We aimed to examine dynamic cardiac vagal regulation in children with CVS compared to healthy controls.

gastroenterology & hepatology
Isozyme specificity of rat liver glutathione S-transferases in the formation of PGF2 alpha and PGE2 from PGH2.

M. Chang,Y. Hong,J. Burgess,C. Tu,C. Reddy

IF: 4.114

Archives of Biochemistry and Biophysics

Abstract:When prostaglandin H2 (PGH2) was incubated with a mixture of glutathione S-transferases (GSTs) obtained from S-hexylglutathione affinity chromatography, as much as 40% of it was transformed into a prostanoid whose Rf value corresponded to that of the standard PGF2 alpha. The reaction product was identified as PGF2 alpha by cochromatography with a standard on TLC and HPLC. The stereochemistry of the hydroxyl groups on C-9 and C-11 of the cyclopentane ring was confirmed by mass-spectral analysis of the butylboronate derivative of the reaction product. Neither PGE2 nor PGD2 could substitute for PGH2 in the reaction mixture, indicating that the mechanism of formation of PGF2 alpha is a direct two-electron reduction of the endoperoxide moiety and not through a reduction of the keto group on PGE2 or PGD2. Individual GST isozymes exhibited distinct differences in their catalytic rates of formation of PGF2 alpha from PGH2. Among various GSTs, isozyme IV, a homodimer of Ya size subunit showed the highest activity with a Vmax value of approximately 6000 nmol.min-1.mg-1. In general, the isozymes containing Ya and Yc subunits exhibited relatively high activity toward PGH2, indicating that it is the non-selenium-dependent glutathione peroxidase activity associated with the GSTs that might be responsible for the reduction of PGH2 to PGF2 alpha. Interestingly, isozyme IV also exhibited the highest PGE2 forming activity with a Vmax value of approximately 3000 nmol.min-1.mg-1 followed by isozyme I, a homodimer of Yb subunit, which had a Vmax value of 420 nmol.min-1.mg-1. Based on these results, it appears that the GSTs play an important role in the biosynthesis of classical PGs. Therefore, it is conceivable that the tissue-specific formation of PGF2 alpha and PGE2 might, in part, be due to the relative distribution of these enzyme activities in a given tissue. Our results have not only confirmed the previously published reports (E. Christ-Hazelhof et al. (1976) Biochim. Biophys. Acta 450, 450-461), but also have characterized the specificity of GST isozymes in the formation of PGF2 alpha.
Treatment principles in adults and development of patient‐reported outcomes in cyclic vomiting syndrome

Yaozhu J. Chen,Milan Patel,Thangam Venkatesan

DOI: https://doi.org/10.1111/nmo.14910

2024-11-27

Neurogastroenterology & Motility

Abstract:Roadmap to Patient‐Focused Outcome Measurement in Clinical Trials. Source: US FDA, "Patient‐Focused Drug Development: Selecting, Developing, or Modifying Fit‐for‐Purpose Clinical Outcome Assessments", Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholder. Background Cyclic vomiting syndrome is a chronic disorder of gut‐brain interaction that is present in both adults and children. It is characterized by severe nausea, vomiting, abdominal pain, and several non‐GI symptoms. It is also associated with several comorbid conditions such as anxiety and depression, which affect overall health care outcomes. Methods This article delineates treatment principles, encompassing both abortive interventions and prophylactic regimens currently recommended for CVS. However, it underscores a critical concern: the absence of FDA‐approved medications for CVS treatment, with existing therapies relying on retrospective and open‐labeled trials. Key results This article emphasizes the pressing need for the development of CVS‐specific outcome assessment tools to facilitate more accurate evaluation and robust data collection for the future studies. In exploring this deficiency, the manuscript also presents the up‐to‐date data and development that enhances our comprehension of patient‐centric concepts, and the challenges faced in creating CVS‐specific tools, and presents a roadmap for their development. Addressing this gap is crucial for advancing our understanding of CVS and optimizing patient care. Conclusions and Inferences This elucidates the current state of CVS management but also advocates for a future where tailored tools enhance our ability to measure and improve the outcomes for individuals with this debilitating disorder.

gastroenterology & hepatology,neurosciences,clinical neurology
Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis

Y Taché

Abstract:The characterization of corticotropin-releasing factor (CRF) and CRF receptors and the use of specific CRF antagonists have paved the way to establish a key role of brain CRF in the coding of the stress response. CRF injected into the cerebrospinal fluid or the periphery inhibits gastric emptying in various species. The paraventricular nucleus of the hypothalamus and dorsal vagal complex are brain sites of action for CRF. Endogenous brain CRF plays a role in mediating psychological, physical, somatovisceral, and immunological stress-induced delayed gastric emptying in rats. Postoperative gastric ileus is also prevented by peripheral injection of CRF antagonists. Cyclic vomiting syndrome (CVS) is precipitated by stimuli or states associated with stimulation of CRF release, and the resulting endocrine, autonomic, and visceral changes are indicative of central CRF activation. Moreover, empiric pharmacotherapy alleviating CVS symptoms are known experimentally to block CRF release or action. The relevance of central CRF activation in the pathophysiology of CVS deserves further consideration.
Worldwide Prevalence and Description of Cyclic Vomiting Syndrome According to the Results of the Rome Foundation Global Epidemiology Study

Arantzazu Izagirre,Cristina Sarasqueta,Joel Flores-Arriaga,María C. Aso,María Pérez,Jan Tack,I-Hsuan Huang,Ami D Sperber,Olafur S Palsson,Shrikant I Bangdiwala,Mauro D'Amato,Ángel Lanas,Beatriz Lobo,Carmen Alonso-Cotoner,Javier Santos,Luis Bujanda

DOI: https://doi.org/10.14309/ajg.0000000000003105

2024-09-26

The American Journal of Gastroenterology

Abstract:Background & Aims: Cyclic vomiting syndrome (CVS) is a disorder of gut-brain interaction (DGBI) of unknown origin. This study aimed to evaluate the global prevalence of this disorder and its associated factors. Methods: Data were collected from nationwide Internet surveys in 26 countries, with subjects evenly distributed by age, sex and country. The survey included the Rome IV questionnaire as well as an extensive supplemental questionnaire to evaluate additional factors. Results: 54,127 participants completed the questionnaire (51% male, mean age 44.3 years). The pooled prevalence of CVS was 0.3% (95% CI 0.3-0.4%; n=187), highest in Brazil (1%, 95% CI 0.6-1.5), and lowest in Japan and Germany (with no subject who fulfilled the criteria for CVS). The mean age of participants with CVS was 36.7 years (standard deviation 13.5) and it was more common in females (56.7% vs 43.5%). Factors independently associated with this syndrome were female sex (OR 1.52, 95% CI 1.13-2.03), young age (OR 2.57, 95% CI 1.34-4.94, for people between the ages of 18 and 39 years, compared to those older than 65 years), depression (OR 3.14, 95% CI 2.05-4.82, p<0.001) and anxiety (OR 1.79, 95% CI 1.15-2.78, p<0.001). Individuals with CVS had impaired quality of life (QoL) (PROMIS-10 score: physical QoL mean, 12.9 vs 15.5, p<0.001; mental QoL mean 12.3 vs 14.4, p<0.001) compared to others. Conclusions: CVS is a relatively common disorder that has a negative impact on quality of life. It is important to raise awareness on this syndrome to avoid underdiagnosis and improve clinical practice.

gastroenterology & hepatology
S782 Nutritional Status and Eating Patterns in Patients With Cyclic Vomiting Syndrome

Subanandhini Subramaniam,Saranya Arumugam,Mahima Vijaybhai Vyas,Kristen Roberts,Kebire Gofar,Kristin Goheen,Praveen Goday,Thangam Venkatesan

DOI: https://doi.org/10.14309/01.ajg.0001032496.71862.3c

2024-10-26

The American Journal of Gastroenterology

Abstract:Cyclic Vomiting Syndrome (CVS) is a disorder of gut-brain interaction, characterized by recurrent episodes of nausea, vomiting, and abdominal pain. Episodes last several days to a week and frequency varies from 3 episodes/year to 2/month where patients are unable to eat or drink placing them at risk of malnutrition and possible restrictive eating. Despite this, there are no data on the nutrition status or the prevalence of disordered eating in CVS. We aimed to determine the presence of malnutrition risk, food insecurity and disordered eating among patients with CVS.

gastroenterology & hepatology
It's Not Cyclic Vomiting Syndrome Until Dietl's is Ruled Out: A Case for Point of Care Renal Ultrasound

Christopher Thom,Michael Larsen,Matthew Kongkatong,Jakob Ottenhoff,James Moak

DOI: https://doi.org/10.1016/j.jemermed.2024.05.003

Abstract:Background: Abdominal pain and vomiting are frequent complaints for pediatric patients presenting to the Emergency Department (ED). When a diagnosis such as chronic abdominal pain, cyclic vomiting, or abdominal migraine has previously been made, it can lead to diagnostic momentum and confirmation bias on behalf of the treating physician. Dietl's crisis is a commonly missed diagnosis in the pediatric population that presents with intermittent episodes of pain and vomiting. It can be readily diagnosed at the bedside by the emergency physician (EP) through the employment of point of care ultrasound (POCUS). Case series: We present two cases of pediatric patients with episodic abdominal pain and vomiting who were previously diagnosed with cyclic vomiting syndrome. In both cases, pediatric gastroenterology evaluations had occurred with negative diagnostic testing having been performed. Both patients also presented to their primary pediatrician and the ED multiple times with each encounter resulting in treatment of symptoms and discharge. Each patient eventually presented to the ED when an EP was present who performed a renal POCUS. In each patient, the POCUS revealed severe unilateral hydronephrosis. Subsequent workup confirmed the diagnosis of Dietl's crisis as the etiology of symptoms. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: In pediatric patients, EPs should be wary of the diagnosis of cyclic vomiting syndrome until ureteral obstruction has been ruled out. A bedside POCUS can rapidly establish this diagnosis and potentially preclude recurrent health care visits, unnecessary diagnostic testing, and permanent loss of renal function.
Identical karyotypes in synchronous bilateral clear cell renal cell carcinomas.

M. Hirsch,M. Weinstein,Ann Thomas,P. Dal Cin

DOI: https://doi.org/10.1016/S0165-4608(02)00612-X

2002-11-01

Cancer Genetics and Cytogenetics

Abstract:

A novel adaptive spectrum forming filter: Application in cognitive ultra-wideband

Advances of diagnosis in children with cyclic vomiting syndrome

Cyclic vomiting syndrome: A narrative review and guide to management

Lumbar extensor fatigue and circumferential ankle pressure impair ankle joint motion sense

Cyclic Vomiting Syndrome in Children and Adults: What Is New in 2018?

Reversible Splenial Lesion Syndrome in Children with Benign Convulsions Associated with Mild Gastroenteritis: A Retrospective Study of Five Cases

Children with Cyclic Vomiting Syndrome: Phenotypes, Disease Burden and Mitochondrial DNA Analysis

Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders

Mitochondrial HMG-CoA Synthase Deficiency: A Cyclic Vomiting Mimic Without Reliable Biochemical Markers

Exploring cyclic vomiting syndrome (CVS) worldwide: Current epidemiological insights and recent developments

Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium

S803 Recent Findings on Clinical and Economic Outcomes of Cyclic Vomiting Syndrome: An Analysis of the National Inpatient Database

Recurrent Severe Vomiting Due to Hyperthyroidism

Cardiac Vagal Regulation is Impeded in Children with Cyclic Vomiting Syndrome

Isozyme specificity of rat liver glutathione S-transferases in the formation of PGF2 alpha and PGE2 from PGH2.

Treatment principles in adults and development of patient‐reported outcomes in cyclic vomiting syndrome

Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis

Worldwide Prevalence and Description of Cyclic Vomiting Syndrome According to the Results of the Rome Foundation Global Epidemiology Study

S782 Nutritional Status and Eating Patterns in Patients With Cyclic Vomiting Syndrome

It's Not Cyclic Vomiting Syndrome Until Dietl's is Ruled Out: A Case for Point of Care Renal Ultrasound

Identical karyotypes in synchronous bilateral clear cell renal cell carcinomas.